Navigation Links
Safety and Efficacy of OrbusNeich's Genous™ Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Date:1/10/2011

HONG KONG, Jan. 10, 2011 /PRNewswire/ -- Data from patients who are considered high-risk due to underlying clinical conditions and who cannot be treated with drug eluting stents (DES) and the accompanying requirement of long-term dual antiplatelet therapy (DAPT) showed positive safety and short- and long-term clinical outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online in EuroIntervention (published-ahead-of-print, August 2010).  

Known contraindications for DAPT include hypersensitivity or allergy to aspirin, a hemorrhagic risk, or a planned surgery shortly after percutaneous coronary intervention (PCI) that would require cessation of DAPT.

In the study, the major adverse cardiac events (MACE) free survival rate in patients treated with the Genous Stent was 80.6% after one year.  Between year one and year two, no additional MACE were observed. In patients who underwent surgical treatment shortly after PCI, no perioperative MACE or thrombotic events occurred.  Despite a very short period of DAPT use of 15 to 30 days, there were no cases of sub-acute, late or very late stent thrombosis in treated patients. The cumulative incidence of cardiac death was 1.6%, which is low considering the high risk patient population.

"The Genous Stent is an important and extremely attractive option for interventional cardiologists to safely manage high-risk patients who are contraindicated for prolonged DAPT and, therefore, should not receive a DES," said Paolo Scacciatella, M.D., Ph.D., of the Molinette Hospital Turin, Italy, and principal investigator of the study.  "This is the first study that demonstrates the feasibility and efficacy of the Genous Stent in this particular segment of patients who are challenging to treat."

Emanuele Meliga, M.D., Ph.D., FESC, of Ordine Mauriziano Hospital in Turin, Italy, and corresponding author of the publication added, "We have observe
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
4. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
5. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
6. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
9. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
10. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/942kh3/micro_market ... "Micro Market Monitor: North American Dermatology Diagnostic Devices ... http://photos.prnewswire.com/prnh/20130307/600769 Cosmetic ... has resulted in fueling the overall demand of ... of these dermatology devices is to assist in ...
(Date:12/19/2014)... DIEGO , Dec. 18, 2014  RESMED INC. (NYSE: ... its second quarter of fiscal year 2015 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3ResMed To Announce Second Quarter 2015 Results 2
... Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged ... of human viral diseases, today announced that two abstracts have ... the European Association for the Study of the Liver (EASL, ... can now be viewed at the EASL website at www.easl.eu. ...
... (Nasdaq: IDIX ) announced today that management will ... Stock Conference on Monday, March 14, 2011 at 12:00 p.m. ... California and at the Barclays Capital 2011 Global Healthcare Conference ... the Loews Miami Hotel, Florida. The live and ...
Cached Medicine Technology:Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) 3
(Date:12/21/2014)... Hills, Ca (PRWEB) December 21, 2014 ... Khanna was a guest at the Aspen Helicopters holiday ... kids and a Santa with sleigh, flown by an ... helicopter appeared invisible; only Santa with sleigh was visible.(please ... during day and night. Dr.Khanna has helped many pilots ...
(Date:12/21/2014)... AngelWeddingDress.com’s new collection of 2015 spring wedding dresses ... new designs in this collection, and all of them ... AngelWeddingDress.com promises to provide the most fashionable designs ... many fashion trends come and go. If ladies have ... AngelWeddingDress.com is ready to assist. , “These new ...
(Date:12/21/2014)... HealthDay Reporter FRIDAY, Dec. 19, ... addictive than traditional cigarettes, new research finds. Even ... cigarettes, thousands of ex-smokers said they have fewer cravings and ... need to smoke, researchers reported. "The pattern ... e-cig use than for tobacco use," said lead researcher Jonathan ...
(Date:12/21/2014)... NY (PRWEB) December 21, 2014 The ... 1,400 in a consolidated litigation underway in New Jersey, ... a total of 1,375 claims involving the birth control ... Court. These lawsuits were filed by women who allege ... have led to uterine perforations and other complications they ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage ... and the Doors International Ballroom at the Hilton Hotel ... the only time that Morrison's mother would see her ... 1967. According to Hawley, “This would be the Doors ... Alexandria Roller Rink earlier that year and would return ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3
... 62-cent increase on cigarettesMINNEAPOLIS, April 23 The ... lot of Minnesotans trying to quit smoking. QUITPLAN ... Minnesota(SM), has seen user volumes spike following the ... 62 cents to expand the State ...
... April 2009 | About 400 cancer therapy ... States) will meet next week in Vienna at an IAEA ... , The three-day International Conference on Advances in Radiation Oncology ... Conference Building M of the Vienna International Center. , ...
... to Mr. Abram for 30-year dedication to promoting awareness ... Michael E. CapuanoSAN FRANCISCO, April 23 The American ... its first EyeSmart(TM) Distinguished Service Award to ... This Old House and host of The ...
... Professor Program at UCSF is described as a national ... scientists conducting innovative research in minority communities in a ... American Journal of Public Health . , The ... Studies, known as CAPS, has been funded by the ...
... MRI scanner sales in Russia, Brazil, and India will ... Research Group WALTHAM, Mass., April 23 According ... diagnostic imaging markets in Brazil, India, and Russia, the ... diagnostic imaging markets in these 3 countries in 2009, ...
... announces the launch of a new menopausal cooling towel , ... ... Key West, FL (Vocus) April 23, 2009 -- CHILL International, Inc. announces ... instant relief for hot flashes and night sweats . CHILL ...
Cached Medicine News:Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 3Health News:IAEA conference to focus on new techniques in cancer treatment 2Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 2Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 3Health News:UCSF HIV/AIDS training program successfully promotes diversity 2Health News:UCSF HIV/AIDS training program successfully promotes diversity 3Health News:Emerging Markets for Diagnostic Imaging Systems Hurt by Economic Crisis 2Health News:Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats 2Health News:Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats 3
Modular Specimen Filing System has five cells that can hold either slides or tissue cassettes....
... an expanded database containing over 330 ... cards, VITEK 2 Compact offers enhanced ... of time (2 to 14 hours), ... microorganisms that contaminate production areas and ...
... is a comprehensive hemodynamic monitoring and ... lab. Patient demographics, clinical hemodynamic ... procedural information all flow seamlessly into ... repetitive data entry. Both ...
... generation product is a patient monitoring system ... parameters, sensed at the tissue level, reflecting ... tissue by low power light and detects ... tissue. The light is guided to the ...
Medicine Products: